Health News
-
Health Magazine
-
Health Company Reports
Advertise
|
About Us
|
Contact Us
|
Press Releases
|
Testimonials
Friday, September 10, 2010
NEWSFEEDS RSS
E-mail:
*
Enter your e-mail address.
Password:
*
Enter the password that accompanies your e-mail.
Password?
|
Sign Up
News and Information for Healthcare Executives
Home
Company Reports
Industry Focus
Associations
Events & Tradeshows
Market Sectors
Blogs
Top Stories in
Healthcare Digital
1 of 10
Chili peppers can cause Skin Cancer
2 of 10
Piramal: Completes first-phase of business formulations
3 of 10
Sun: Settles on Taro with Israeli SC verdict
4 of 10
FDA: Stops Idenix drug studies due to side effects
5 of 10
Vertex: Hepatitis C drug can help patients
6 of 10
Piramal: Cavaal Fininvest to pick up 7.28% stake
7 of 10
Avandia: To be pulled out from market
8 of 10
ProAssurance: Will buy American Physicians Service
9 of 10
Abbott: Discards plans to sell vaccine business
10 of 10
Aboriginal health service: Sees crisis
Health News
Search Healthcare Digital:
Comment
Chili peppers can cause Skin Cancer
BY: n.namazi |
Thu Sep 9, 2010
TAGS:
cancer research
,
Capsaicin
,
Chili peppers
,
health study
,
Skin Cancer
A new research has linked ‘capsaicin’ to skin cancer
Comment
Piramal: Completes first-phase of business formulations
BY: n.namazi |
Thu Sep 9, 2010
TAGS:
Abbott Laboratories
,
Ajay Piramal
,
Bombay Stock Exchange
,
Piramal Healthcare
Piramal Healthcare has announced that it has concluded the first part to sell its domestic formulations business to Abbott.
Comment
Sun: Settles on Taro with Israeli SC verdict
BY: n.namazi |
Thu Sep 9, 2010
TAGS:
Pharmaceuticals
,
Sarabjit Kour
,
Sun Pharmaceutical
,
Taro Pharmaceutical
The Israeli SC rejected an appeal by Taro Pharmaceutical to block Sun Pharmaceutical from raising its stake in the company.
Comment
FDA: Stops Idenix drug studies due to side effects
BY: n.namazi |
Wed Sep 8, 2010
TAGS:
biopharmaceuticals
,
FDA
,
food and drug administration
,
Idenix Pharmaceuticals
Shares of Idenix Pharmaceuticals were half after federal regulators halted development of its two hepatitis drugs.
Comment
Vertex: Hepatitis C drug can help patients
BY: n.namazi |
Wed Sep 8, 2010
TAGS:
boceprevir
,
Hepatitis C drug
,
telaprevir
,
Vertex Pharmaceuticals Inc
Vertex Pharmaceuticals Inc. has said that its Hepatitis C drug ‘telaprevir’ can greatly benefit patients.
Comment
Piramal: Cavaal Fininvest to pick up 7.28% stake
BY: n.namazi |
Tue Sep 7, 2010
TAGS:
Abbott Laboratories
,
Bombay Stock Exchange
,
BSE
,
Cavaal Fininvest
,
Piramal Healthcare Ltd
Piramal Healthcare Ltd has announced that Cavaal Fininvest will pick up 7.28 percent stake in the company.
Comment
Avandia: To be pulled out from market
BY: n.namazi |
Tue Sep 7, 2010
TAGS:
Avandia
,
British Medical Journal
,
GlaxoSmithKline
,
GSK
,
rosiglitazone
British Medical Journal wants Avandia to be withdrawn from the market.
Comment
ProAssurance: Will buy American Physicians Service
BY: n.namazi |
Mon Sep 6, 2010
TAGS:
American Physicians Service Group Inc
,
ProAssurance Corp
,
ProAssurance Corporation
ProAssurance Corp has agreed to buy American Physicians Service Group Inc.
Comment
Abbott: Discards plans to sell vaccine business
BY: n.namazi |
Mon Sep 6, 2010
TAGS:
Abbott Laboratories
,
GlaxoSmithKline PLC
,
Novartis AG
,
Solvay Pharmaceuticals
,
vaccines business
Abbott Laboratories has abandoned its plan to sell its vaccines business.
Comment
Aboriginal health service: Sees crisis
BY: n.namazi |
Sat Sep 4, 2010
TAGS:
Aboriginal health service
,
health service
,
Katungal health service
1
2
3
4
5
6
7
8
9
…
next ›
last »
Current Issue
Back Issues
Other Magazines
September Issue Live Today
Sign Up
to receive the magazine directly to your inbox monthly
Aug 10
Jul 10
Jun 10
May 10
View More
Follow us
Join us on Facebook
Follow us on Twitter
Subscribe to RSS